FDA guideline on BE, draft August 2021 [BE/BA News]

posted by Achievwin – US, 2021-08-23 23:35 (1417 d 23:09 ago) – Posting: # 22534
Views: 4,910

❝ FDA updated the canonical BE guideline for ANDAs. Draft. :-)


Comments period is open till October 22, 2021, Therefore any issues bothering/benefit ANDA folks can be sent to FDA as comments for consideration.

FDA decided to split BA/BE guidance into two guidance 1) for ANDA filings and 2) for IND/NDAs

More elaborate explanations of each aspect.

Complete thread:

UA Flag
Activity
 Admin contact
23,433 posts in 4,931 threads, 1,674 registered users;
39 visitors (0 registered, 39 guests [including 11 identified bots]).
Forum time: 22:45 CEST (Europe/Vienna)

It has yet to be proven
that intelligence has any survival value.    Arthur C. Clarke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5